Menarini Group presenta nuevos datos del estudio ELEVATE de elacestrant en combinación con capivasertib ...Middle East

- Menarini Group presenta nuevos datos del estudio de fase 1b/2 ELEVATE de elacestrant en combinación con capivasertib en pacientes con cáncer de mama metastásico (CMm) ER+, HER2- en la reunión anual de la Sociedad Estadounidense de Oncología Clínica (ASCO) de 2026 Se presentarán análisis...

Hence then, the article about menarini group presenta nuevos datos del estudio elevate de elacestrant en combinacion con capivasertib was published today ( Friday 29/05/2026 - 12:30 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Menarini Group presenta nuevos datos del estudio ELEVATE de elacestrant en combinación con capivasertib )

Also on site :

• Congress passes war powers measure for first time, rebuking Trump's war with Iran
• Olympic gold medalist Haley Winn visits Plank Road South Elementary in Webster
• Best Prime Day 2026 Tech Deals Under $100: Save Up to 75% on Bose, Beats by Dre, Samsung & Other Top Brands